vs

Side-by-side financial comparison of Cycurion, Inc. (CYCU) and VSEE HEALTH, INC. (VSEE). Click either name above to swap in a different company.

VSEE HEALTH, INC. is the larger business by last-quarter revenue ($3.9M vs $3.5M, roughly 1.1× Cycurion, Inc.). Cycurion, Inc. runs the higher net margin — -141.2% vs -200.0%, a 58.7% gap on every dollar of revenue. On growth, VSEE HEALTH, INC. posted the faster year-over-year revenue change (5.1% vs -13.1%). VSEE HEALTH, INC. produced more free cash flow last quarter ($-1.9M vs $-3.5M). Over the past eight quarters, VSEE HEALTH, INC.'s revenue compounded faster (55.6% CAGR vs -8.6%).

VSEE HEALTH, INC. is a US-based telehealth technology firm offering HIPAA-compliant virtual care platforms, remote consultation tools, and chronic disease management solutions. It primarily serves healthcare providers, enterprise clients and nonprofits across North America and select global markets.

CYCU vs VSEE — Head-to-Head

Bigger by revenue
VSEE
VSEE
1.1× larger
VSEE
$3.9M
$3.5M
CYCU
Growing faster (revenue YoY)
VSEE
VSEE
+18.2% gap
VSEE
5.1%
-13.1%
CYCU
Higher net margin
CYCU
CYCU
58.7% more per $
CYCU
-141.2%
-200.0%
VSEE
More free cash flow
VSEE
VSEE
$1.6M more FCF
VSEE
$-1.9M
$-3.5M
CYCU
Faster 2-yr revenue CAGR
VSEE
VSEE
Annualised
VSEE
55.6%
-8.6%
CYCU

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CYCU
CYCU
VSEE
VSEE
Revenue
$3.5M
$3.9M
Net Profit
$-5.0M
$-7.9M
Gross Margin
12.1%
46.7%
Operating Margin
-141.7%
-87.6%
Net Margin
-141.2%
-200.0%
Revenue YoY
-13.1%
5.1%
Net Profit YoY
-546.8%
-144.7%
EPS (diluted)
$-11.09
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYCU
CYCU
VSEE
VSEE
Q4 25
$3.5M
$3.9M
Q3 25
$3.8M
$4.0M
Q2 25
$3.9M
$3.4M
Q1 25
$3.9M
$3.3M
Q4 24
$4.1M
$3.7M
Q3 24
$4.5M
$3.4M
Q2 24
$5.0M
$1.7M
Q1 24
$4.2M
$1.6M
Net Profit
CYCU
CYCU
VSEE
VSEE
Q4 25
$-5.0M
$-7.9M
Q3 25
$-3.1M
$-289.7K
Q2 25
$-5.3M
$-2.6M
Q1 25
$-10.2M
$-4.0M
Q4 24
$1.1M
$-3.2M
Q3 24
$116.1K
$-53.9M
Q2 24
$306.1K
$-634.1K
Q1 24
$-312.5K
$62.8K
Gross Margin
CYCU
CYCU
VSEE
VSEE
Q4 25
12.1%
46.7%
Q3 25
7.1%
52.1%
Q2 25
6.1%
46.9%
Q1 25
17.5%
56.0%
Q4 24
37.9%
63.8%
Q3 24
16.1%
83.0%
Q2 24
20.5%
45.4%
Q1 24
8.2%
76.2%
Operating Margin
CYCU
CYCU
VSEE
VSEE
Q4 25
-141.7%
-87.6%
Q3 25
-118.2%
-51.7%
Q2 25
-96.9%
-66.5%
Q1 25
-260.9%
-55.1%
Q4 24
31.9%
-81.1%
Q3 24
9.4%
-1737.8%
Q2 24
14.6%
-54.5%
Q1 24
-0.8%
6.4%
Net Margin
CYCU
CYCU
VSEE
VSEE
Q4 25
-141.2%
-200.0%
Q3 25
-81.5%
-7.3%
Q2 25
-136.1%
-77.1%
Q1 25
-264.8%
-119.2%
Q4 24
27.5%
-85.9%
Q3 24
2.6%
-1607.5%
Q2 24
6.1%
-37.0%
Q1 24
-7.4%
3.9%
EPS (diluted)
CYCU
CYCU
VSEE
VSEE
Q4 25
$-11.09
$-0.31
Q3 25
$-1.59
$-0.02
Q2 25
$-0.15
$-0.16
Q1 25
$-0.56
$-0.24
Q4 24
$1.56
$-1.96
Q3 24
$0.11
$-3.58
Q2 24
$0.01
$-0.12
Q1 24
$-0.02
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYCU
CYCU
VSEE
VSEE
Cash + ST InvestmentsLiquidity on hand
$5.3M
$5.3M
Total DebtLower is stronger
$2.7M
Stockholders' EquityBook value
$20.1M
$5.5M
Total Assets
$33.5M
$22.4M
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYCU
CYCU
VSEE
VSEE
Q4 25
$5.3M
$5.3M
Q3 25
$3.7M
$472.8K
Q2 25
$1.0M
$291.6K
Q1 25
$410.1K
Q4 24
$38.7K
$326.1K
Q3 24
$2.3M
Q2 24
$1.1M
Q1 24
$724
Total Debt
CYCU
CYCU
VSEE
VSEE
Q4 25
$2.7M
Q3 25
$3.4M
Q2 25
$3.0M
Q1 25
$2.6M
Q4 24
$1.9M
Q3 24
$1.9M
Q2 24
$2.4M
Q1 24
Stockholders' Equity
CYCU
CYCU
VSEE
VSEE
Q4 25
$20.1M
$5.5M
Q3 25
$19.1M
$-5.6M
Q2 25
$14.0M
$-5.7M
Q1 25
$12.9M
$-3.5M
Q4 24
$3.5M
$-18.5K
Q3 24
$-3.7M
$933.1K
Q2 24
$-3.4M
$53.1M
Q1 24
$-2.8M
$-13.2M
Total Assets
CYCU
CYCU
VSEE
VSEE
Q4 25
$33.5M
$22.4M
Q3 25
$32.3M
$18.7M
Q2 25
$30.7M
$18.2M
Q1 25
$31.5M
$19.4M
Q4 24
$25.6M
$20.0M
Q3 24
$2.9M
$22.3M
Q2 24
$2.7M
$78.6M
Q1 24
$3.1M
$1.4M
Debt / Equity
CYCU
CYCU
VSEE
VSEE
Q4 25
0.50×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
2.08×
Q2 24
0.05×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYCU
CYCU
VSEE
VSEE
Operating Cash FlowLast quarter
$-3.3M
$-1.9M
Free Cash FlowOCF − Capex
$-3.5M
$-1.9M
FCF MarginFCF / Revenue
-98.8%
-49.2%
Capex IntensityCapex / Revenue
5.3%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.5M
$-3.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYCU
CYCU
VSEE
VSEE
Q4 25
$-3.3M
$-1.9M
Q3 25
$-2.5M
$-754.5K
Q2 25
$-3.6M
$-324.6K
Q1 25
$-2.7M
$-440.5K
Q4 24
$-205.7K
$-3.0M
Q3 24
$-315.2K
$-221.0K
Q2 24
$-578.0K
$-3.2M
Q1 24
$-272.4K
$579.3K
Free Cash Flow
CYCU
CYCU
VSEE
VSEE
Q4 25
$-3.5M
$-1.9M
Q3 25
$-2.6M
$-761.8K
Q2 25
$-3.7M
$-328.2K
Q1 25
$-2.8M
$-452.4K
Q4 24
$-310.7K
$-3.0M
Q3 24
$-420.2K
$-226.0K
Q2 24
$-711.0K
$-3.2M
Q1 24
$-377.4K
$570.5K
FCF Margin
CYCU
CYCU
VSEE
VSEE
Q4 25
-98.8%
-49.2%
Q3 25
-66.9%
-19.1%
Q2 25
-94.2%
-9.7%
Q1 25
-72.7%
-13.6%
Q4 24
-7.6%
-79.8%
Q3 24
-9.4%
-6.7%
Q2 24
-14.2%
-187.6%
Q1 24
-8.9%
35.2%
Capex Intensity
CYCU
CYCU
VSEE
VSEE
Q4 25
5.3%
0.2%
Q3 25
2.5%
0.2%
Q2 25
2.7%
0.1%
Q1 25
1.8%
0.4%
Q4 24
2.6%
0.1%
Q3 24
2.4%
0.1%
Q2 24
2.7%
2.1%
Q1 24
2.5%
0.5%
Cash Conversion
CYCU
CYCU
VSEE
VSEE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.18×
Q3 24
-2.71×
Q2 24
-1.89×
Q1 24
9.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CYCU
CYCU

Segment breakdown not available.

VSEE
VSEE

Professional Services And Other Fees$3.1M79%
Other$823.2K21%

Related Comparisons